Keywords: مجوز بازاریابی; Clinical trials; New regulation; Reporting member states; Interventional study; EU; European Union; EC; European Commission; MA; Marketing authorization; CI; Informed Consent; MS; member states; rMS; reporting member state;
مقالات ISI مجوز بازاریابی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مجوز بازاریابی; Marketing authorization; Failure; Generic; Bioequivalence; Therapeutic equivalence; Decentralised procedure;
Keywords: مجوز بازاریابی; biosimilar pharmaceuticals; traceability; risk management; substitution; health care costs; ANSM; French National Agency for Medicines and Health Products Safety (Agence Nationale de Sécurité du Médicament et des Produits de Santé); ASMR; improvement
Keywords: مجوز بازاریابی; advanced therapy medicinal product; advanced therapy medicinal product with hospital exemption; genetically modified organism; market access; ADI; aid for development of innovation; AFM; French Association against Myopathies (Association Française contre
Medicinal Product Regulation: Portugal׳s Framework
Keywords: مجوز بازاریابی; marketing authorization; medicinal products regulation; National Regulatory Agency; Portugal;
The “Temporary Recommendations for Use”: A dual-purpose regulatory framework for off-label drug use in France
Keywords: مجوز بازاریابی; Policy development; Temporary Recommendations for Use; Off-label drug use; Marketing authorization;
Medico-economic Evaluation of Health Products in the Context of the Social Security Financing Act for 2012
Keywords: مجوز بازاریابی; medico-economic evaluation; price of medicinal products and medical devices; reimbursement; innovative medicinal products; innovative medical devices; budget impact; efficiency; cost-efficacy ratio; guidelines; acceptability threshold; Economic and Public
Population access to new vaccines in European countries
Keywords: مجوز بازاریابی; Europe; Marketing approval; Marketing authorization; Population access; Regulation; Vaccine
Pharmacoepidemiology Studies: what Levels of Evidence and how can They be Reached?
Keywords: مجوز بازاریابی; evaluation; effectiveness; risk; treated population; level of evidence; AEs; adverse effects; CEBM; center for evidencebased medicine; DB; databases; EGB; representative sample of Health insurance beneficiaries (échantillon généraliste de bénéficiair
Off-label Prescriptions: how to Identify Them, Frame Them, Announce Them and Monitor Them in Practice?
Keywords: مجوز بازاریابی; MA; off-MA; conditonal MA; temporary treatment protocol; regulation; temporary use recommendations; Afssaps; French Agency for the Safety and Health Products (Agence française de sécurité sanitaire des produits de santé); ANSM; National Security Agenc
Réflexions sur les critères d'évaluation des traitements anticancéreux lors des procédures d'autorisation de mise sur le marché
Keywords: مجوز بازاریابی; traitements anticancéreux; autorisation de mise sur le marché; représentations; qualité de vie; durée de vie; cancer treatments; marketing authorization; representations; quality of life; length of life;
Contribution of Modeling Approaches and Virtual Populations in Transposing the Results of Clinical Trials into Real Life and in Enlightening Public Health Decisions
Keywords: مجوز بازاریابی; modeling; simulation; clinical trials; public decision; virtual populations; CEPS; Economic committee of the health products in France (Comité économique des produits de santé); CTV; Technical committe of vaccinations in France (Comité technique des v
Personalized Medicine: how to Switch from the Concept to the Integration into the Clinical Development Plan to Obtain Marketing Authorization
Keywords: مجوز بازاریابی; personalized medicine; biomarkers; phasis of development; economic model; Theranostic; DRESS syndrome; drug reaction with eosinophilia and systemic symptoms syndrom; EGFR; epidermal growth factor receptor; EMA; European Medicines Agency; FDA; Food and Dru
Les « nouveaux » radiopharmaceutiques
Keywords: مجوز بازاریابی; Radiopharmaceutiques; Afssaps; AMM; Médicaments expérimentauxRadiopharmaceuticals; French sanitary security and health products agency; Marketing authorization; Experimental medicine